A collection of stock notes from around the web.
August 21, 2009
An Undervalued Hidden Gem
that one of their Hidden Gems selections, Innophos Holdings appears to be cheap with its 2.1 P/E ratio and 2.4 P/FCF ratio.
August 17, 2009
The Case for Stryker
The Fool makes a good case for owning Stryker in
. The company is an official Inside Value selection and the Fool owns shares of the company.
August 11, 2009
$30 Price Target on Human Genome Sciences
that Leerink has set a new price target of $30 on Human Genome Sciences due to the likely hood of positive Phase II trial data for BLISS-76.
Human Genome Sciences
August 5, 2009
On Capital Source
, the Fool owns shares of Capital Source.